Area of research
Infectious Diseases · Epidemiology
Research interest
Research interests include COVID-19 Clinical Research Studies, Sepsis Diagnosis and Treatment, Kawasaki Disease and Coronary Complications, and Mechanical Circulatory Support Devices.
Respiratory Syncytial Virus Disease Burden and Nirsevimab Effectiveness in Young Children From 2023-2024
Molecular mimicry in multisystem inflammatory syndrome in children
Executive Summary: The Pediatric Extracorporeal Membrane Oxygenation Anticoagulation CollaborativE (PEACE) Consensus Conference*
Infants Admitted to US Intensive Care Units for RSV Infection During the 2022 Seasonal Peak
Extracorporeal Membrane Oxygenation Characteristics and Outcomes in Children and Adolescents With COVID-19 or Multisystem Inflammatory Syndrome Admitted to U.S. ICUs*
Community-Onset Bacterial Coinfection in Children Critically Ill With Severe Acute Respiratory Syndrome Coronavirus 2 Infection
783: EPIDEMIOLOGY OF INTRACRANIAL HEMORRHAGE IN CHILDREN SUPPORTED BY EXTRACORPOREAL MEMBRANE OXYGENATION
Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C
Health Impairments in Children and Adolescents After Hospitalization for Acute COVID-19 or MIS-C
Comparative Effectiveness of Diversion of Cerebrospinal Fluid for Children With Severe Traumatic Brain Injury
NFKB2 haploinsufficiency identified via screening for IFN-α2 autoantibodies in children and adolescents hospitalized with SARS-CoV-2–related complications
Measurement of Severe Acute Respiratory Syndrome Coronavirus 2 Antigens in Plasma of Pediatric Patients With Acute Coronavirus Disease 2019 or Multisystem Inflammatory Syndrome in Children Using an Ultrasensitive and Quantitative Immunoassay
Changes in Distribution of Severe Neurologic Involvement in US Pediatric Inpatients With COVID-19 or Multisystem Inflammatory Syndrome in Children in 2021 vs 2020
Life-Threatening Complications of Influenza vs Coronavirus Disease 2019 (COVID-19) in US Children
<i>DDX58</i> Is Associated With Susceptibility to Severe Influenza Virus Infection in Children and Adolescents
Tachyarrhythmias During Hospitalization for COVID‐19 or Multisystem Inflammatory Syndrome in Children and Adolescents
Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19
Neurologic Involvement in Children and Adolescents Hospitalized in the United States for COVID-19 or Multisystem Inflammatory Syndrome
Multisystem Inflammatory Syndrome in Children — Initial Therapy and Outcomes
Data-driven clustering identifies features distinguishing multisystem inflammatory syndrome from acute COVID-19 in children and adolescents
Exuberant fibroblast activity compromises lung function via ADAMTS4
Postdischarge Outcome Domains in Pediatric Critical Care and the Instruments Used to Evaluate Them: A Scoping Review
Outcomes of pediatric patients with oncologic disease or following hematopoietic stem cell transplant supported on extracorporeal membrane oxygenation: The PEDECOR experience
RIG-I and TLR4 responses and adverse outcomes in pediatric influenza-related critical illness
Vancomycin Monotherapy May Be Insufficient to Treat Methicillin-resistant <i>Staphylococcus aureus</i> Coinfection in Children With Influenza-related Critical Illness